These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 14676775)

  • 21. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
    Pumannova M; Roubalova K; Vitek A; Sajdova J
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].
    Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME
    Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients].
    Xu LP; Huang XJ; Guo NL; Ren HY; Zhang YC; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):407-9. PubMed ID: 14642176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience.
    Manteiga R; Martino R; Sureda A; Labeaga R; Brunet S; Sierra J; Rabella N
    Bone Marrow Transplant; 1998 Nov; 22(9):899-904. PubMed ID: 9827819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in cytomegalovirus replication quantified using quantitative polymerase chain reaction and antigenemia after allogeneic stem cell transplantation.
    de la Cruz-Vicente F; Perez-Romero P; Aguilar-Guisado M; Cisneros-Herreros JM; Urbano-Ispizua A; Espigado I
    Transplant Proc; 2010 Oct; 42(8):3230-1. PubMed ID: 20970661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
    Correia-Silva JF; Bruna-Romero O; Resende RG; Miranda LP; Oliveira FE; Costa FO; Xavier SG; Figueiredo-Neves SP; Almeida HC; Bittencourt H; Gomez RS
    Oral Dis; 2010 Mar; 16(2):210-6. PubMed ID: 20374507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
    Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
    Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.
    Asano-Mori Y; Oshima K; Sakata-Yanagimoto M; Nakagawa M; Kandabashi K; Izutsu K; Hangaishi A; Motokura T; Chiba S; Kurokawa M; Hirai H; Kanda Y
    Bone Marrow Transplant; 2005 Nov; 36(9):813-9. PubMed ID: 16151428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.
    Schetelig J; Oswald O; Steuer N; Radonic A; Thulke S; Held TK; Oertel J; Nitsche A; Siegert W
    Bone Marrow Transplant; 2003 Oct; 32(7):695-701. PubMed ID: 13130317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
    Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
    Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant.
    Hebart H; Wuchter P; Loeffler J; Gscheidle B; Hamprecht K; Sinzger C; Jahn G; Dietz K; Kanz L; Einsele H
    Bone Marrow Transplant; 2001 Jul; 28(2):213-8. PubMed ID: 11509941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
    Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
    Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays.
    Gracia-Ahufinger I; Tormo N; Espigado I; Solano C; Urbano-Ispizua A; Clari MA; de la Cruz-Vicente F; Navarro D; Pérez-Romero P
    J Clin Virol; 2010 Jun; 48(2):142-6. PubMed ID: 20395168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
    Tan BH; Chlebicka NL; Low JG; Chong TY; Chan KP; Goh YT
    Transpl Infect Dis; 2008 Oct; 10(5):325-32. PubMed ID: 18627578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.
    Vlieger AM; Boland GJ; Jiwa NM; de Weger RA; Willemze R; de Gast GC; Falkenburg JH
    Bone Marrow Transplant; 1992 Apr; 9(4):247-53. PubMed ID: 1318141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation.
    Humar A; O'Rourke K; Lipton J; Messner H; Meharchand J; Mahony J; Walker I; Wasi P; McGeer A; Moussa G; Chua R; Mazzulli T
    Bone Marrow Transplant; 1999 Jan; 23(1):45-51. PubMed ID: 10037050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.